Fludora® Fusion
Supported by IVCC through scientific advice, laboratory support and rigorous field trials, SumiShield® 50WG, developed by Sumitomo Chemical, offers a new Mode of Action (MOA) Active Ingredient (AI) for vector control.
Supported by IVCC through scientific advice, laboratory support and rigorous field trials, SumiShield® 50WG, developed by Sumitomo Chemical, offers a new Mode of Action (MOA) Active Ingredient (AI) for vector control.
Supported by IVCC through scientific advice, laboratory support and rigorous field trials, SumiShield® 50WG, developed by Sumitomo Chemical, offers a new Mode of Action (MOA) Active Ingredient (AI) for vector control.
Uniting global experts to advance Aedes mosquito control tools, addressing the growing threat of arboviral diseases like dengue and Zika.
IVCC congratulates BASF on the news of the prequalification of Sylando® 240 SC by the World Health Organization (WHO). This is a welcome new mode of action in the indoor residual…
The newly released World Malaria Report, prepared by the World Health Organization (WHO), spotlights a pivotal moment in the fight against malaria. From 2000 to 2023, the global community averted…
Responding to the challenge of gaps in the malaria vector control tool box, IVCC has issued a call for Expressions of Interest (EOI) to fund Proof of Concept (PoC) projects…
From September 19th to 23rd, IVCC attended the International Congress for Tropical Medicine and Malaria(ICTMM) 2024 in Kuching, Malaysia. This congress, hosted by the International Federation for Tropical Medicine, highlighted…
From September 19th to 23rd, IVCC attended the International Congress for Tropical Medicine and Malaria (ICTMM) 2024 in Kuching, Malaysia. This congress, hosted by the International Federation for Tropical Medicine, highlighted global efforts…
We are proud to announce the unveiling of a commemorative plaque for the “Accelerate to Eliminate Malaria Program,” a five-year cooperative agreement funded by USAID and implemented by IVCC.
Malaria No More UK launch their new report as they hosted a reception event alongside the Commonwealth Health Ministers Meeting in Geneva.